Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH mutation status and the development of venous thromboembolism in astrocytoma patients.

Journal of the neurological sciences - 15 Aug 2021

Mandel Jacob J, Youssef Michael, Yust-Katz Shlomit, Patel Akash J, Jalali Ali, Li Ziyi, Wu Jimin, Ludmir Ethan B, de Groot John F

Abstract excerpt

BACKGROUND: Venous thromboembolism (VTE) is a very common adverse event for astrocytoma patients, but validation of proposed risk biomarkers has been elusive. We examine whether the status of the isocitrate dehydrogenase (IDH) gene is a risk factor for the development of venous thromboembolism (VTE) in astrocytoma patients. METHODS: We conducted a retrospective chart review of 282 astrocytoma patients enrolled in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Venous Thromboembolism

Source

Identifiers

PMID: 34146775
DOI: 10.1016/j.jns.2021.117538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH mutation status and the development of venous thromboembolism in astrocytoma patients.PMID 34146775Read ↗

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.Semantic proximity Read ↗

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.Semantic proximity Read ↗

Assessment of venous thromboembolism in adult diffuse-type gliomas: an experience of a quaternary center and a systematic reviewSemantic proximity Read ↗

Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort studySemantic proximity Read ↗

Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma.Semantic proximity Read ↗

Mutant IDH1 and thrombosis in gliomas.Semantic proximity Read ↗

Determining venous thromboembolism risk in patients with adult-type diffuse glioma.Semantic proximity Read ↗

Optimizing the Prediction of Venous Thromboembolis by a Risk Assessment Model in Patients with GlioblastomaSemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.Semantic proximity Read ↗

Cardiovascular events and venous thromboembolism after primary malignant and non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.